Most research was done on doxorubicin-induced cardiomyopathy and for seven genetic variants in CELF4, GPR35, HAS3, RARG, SLC22A17, SLC22A7 and SLC28A3, replication studies were performed without consistent results. This evidence concerns the gene SLC22A7 and cardiomyopathy.